GLP-1 Weight Loss Services in Newport Beach, CA

What Are GLP-1 Receptor Agonists?

GLP-1 receptor agonists mimic glucagon-like peptide-1, a gut-derived hormone that regulates appetite, insulin secretion, and gastric motility. Activating GLP-1 receptors across the brain, pancreas, and GI tract produces sustained appetite suppression, improved blood sugar control, and meaningful reductions in body weight. Key agents include semaglutide (Ozempic, Wegovy), liraglutide (Saxenda), and the dual agonist tirzepatide (Mounjaro, Zepbound).

How GLP-1 Therapy Drives Weight Loss

  • Hypothalamic appetite suppression — reduces hunger signaling at the brain level, lowering overall food drive
  • Extended post-meal satiety — delayed gastric emptying prolongs fullness, reducing total caloric intake naturally
  • Glucose regulation — stabilized post-meal insulin responses reduce fat deposition
  • Craving reduction — meaningful decreases in food-seeking behavior, particularly for energy-dense foods
  • Cardiometabolic benefits — reduced blood pressure, improved lipid profiles, decreased waist circumference
young handsome physician medical robe-with stethoscope

Who Is Our GLP-1 Program in Newport Beach Designed For?

  • Patients in Newport Beach who want a GLP-1 prescription managed by a board-certified Obesity Medicine specialist with real clinical oversight
  • Adults with a BMI of 27-plus with a weight-related condition, or 30-plus, who are clinically appropriate candidates for incretin-based therapy
  • Individuals who have not achieved goals through sustained diet and exercise and are ready for pharmacological support
  • Patients with pre-diabetes, metabolic syndrome, or PCOS who benefit from both the metabolic and weight-management effects of GLP-1 therapy
  • Results-driven Newport Beach residents who want a physician reachable via telemedicine or at their front door throughout treatment.
young handsome physician medical robe-with stethoscope

Our GLP-1 Program Steps in Newport Beach

Step 1: Clinical Evaluation and Agent Selection

Before any medication is selected, Dr. Adonis Saremi reviews your metabolic labs, weight history, comorbidities, and current medications — choosing between semaglutide and tirzepatide requires this full clinical picture.

Step 2: Personalized Dosing Framework

Your Newport Beach GLP-1 program includes an individualized dosing schedule, nutritional guidance tailored to your metabolic response, behavioral coaching, and a realistic weight loss timeline.

Step 3: Ongoing Monitoring

Regular virtual check-ins allow Dr. Adonis Saremi to track weight, lab trends, and clinical response — adjusting your dose proactively to maximize efficacy and manage side effects before they become barriers.

Step 4: Maintenance Transition

The goal is not just reaching a target weight — it is building the foundation to maintain it. Dr. Adonis Saremi designs a structured maintenance phase for every Newport Beach patient.

Why Choose Dr. Adonis Saremi, MD for GLP-1 Therapy in Newport Beach?

Physician Decision-Making at Every Step

Frequently Asked Questions

Which GLP-1 medication produces the most weight loss?

Tirzepatide (Zepbound/Mounjaro) averages 20 to 22 percent weight loss at the highest dose in SURMOUNT trials. Semaglutide (Wegovy) averages approximately 15 percent. The right choice depends on your individual health profile.

Nausea, diarrhea, and constipation are most common during initial titration. These typically improve with continued use. Your physician helps manage tolerability proactively throughout treatment.

Scroll to Top